Trial Profile
Endothelin Blockade in Patients With Single Ventricle Physiology.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 13 Feb 2015
Price :
$35
*
At a glance
- Drugs Bosentan (Primary)
- Indications Congenital heart defects
- Focus Pharmacodynamics
- Acronyms Actelion 1
- 01 Mar 2013 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 12 Jun 2012 Additional lead trial investigator identified as reported by ClinicalTrials.gov.
- 12 Jun 2012 Planned end date changed from 1 Dec 2011 to 1 Aug 2013 as reported by ClinicalTrials.gov.